Grip strength is something people rarely think about until they experience a decline in it. For older adults, loss of grip ...

At this time every year, students in Shelter Island’s National Honor Society sell shamrocks to raise money for the Muscular Dystrophy Association (MDA). MDA provides health care and support services ...

Osteoporosis and sarcopenia are major concerns for aging individuals, often leading to fractures and loss of independence. This article explores myostatin inhibition’s role in improving bone density ...

Videos of astronauts on the Moon show them often bouncing across the lunar surface, helped by the fact that the gravity of our satellite is just one-sixth of Earth’s surface gravity. That experience ...

Chris D. Meletis, N.D. With age, the sails of our sailboat become deflated unless we take a proactive approach to fight the statistical trends. This is never more true than with the loss of muscle ...

Salanersen, a treatment candidate for spinal muscular atrophy (SMA) now in clinical testing, is safe and was shown to stabilize or improve motor function over at least one year of follow-up in ...

Biogen’s successor to Spinraza (nusinersen) has shown benefit in spinal muscular atrophy (SMA) patients who had suboptimal clinical status despite prior administration of gene therapy. In the Phase Ib ...

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms, characterized by muscle wasting, paralysis, dementia ...

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms, characterized by muscle wasting, paralysis, dementia ...

Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsDavid Hallal - ...

Mutations that cause spinal muscular atrophy (SMA) may lead to abnormalities in the development of cells in the spinal cord, a study found.

Data presented at the 2026 Muscular Dystrophy Association meeting could have readthroughs to companies developing therapies for spinal muscular atrophy, Duchenne muscular dystrophy and Becker muscular ...